Sarcoidosis: An underestimated and potentially severe side effect of anti-TNF-alpha therapy

Joint Bone Spine

Volumn 80, Issue 1, 2013, Pages 104-107

  Vigne, Camille ^a,b   Tebib, Jacques Guy ^a,b   Pacheco, Yves ^a,b   Coury, Fabienne ^a,b  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ANTIBIOTIC AGENT; ETANERCEPT; INFLIXIMAB; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ADULT; CASE REPORT; COUGHING; DISEASE DURATION; DRUG WITHDRAWAL; ERYTHEMA NODOSUM; FEMALE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; LETTER; LUNG BIOPSY; LUNG GRANULOMA; LUNG INFILTRATE; LUNG LAVAGE; LYMPH NODE; MEDICAL HISTORY; RHEUMATOID ARTHRITIS; SARCOIDOSIS; THORAX RADIOGRAPHY; TUBERCULIN TEST; WEIGHT REDUCTION;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CHILD; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; SARCOIDOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84872872114     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2012.05.001     Document Type: Letter

References (10)

1. Iannuzzi M.C., Rybicki B.A., Teirstein A.S. Sarcoidosis. N Engl J Med 2007, 357:2153-2165.
2. Daïen C.I., Monnier A., Claudepierre P., et al. Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases. Rheumatology 2009, 48:883-886.
3. Bosè F., Raeli L., Garutti C., et al. Dual role of anti-TNF therapy: enhancement of TCR-mediated T cell activation in peripheral blood and inhibition of inflammation in target tissues. Clin Immunol 2011, 139:164-176.
4. Biton J., Boissier M.C., Bessis N. TNFα: activator or inhibitor of regulatory T cells?. Joint Bone Spine 2012, 79:119-123.
5. Viguier M., Richette P., Bachelez H., et al. Paradoxical cutaneous manifestations during anti-TNF therapy. Joint Bone Spine 2010, 137:64-71.
6. Chen X., Oppenheim J.J. TNF-alpha: an activator of CD4+FoxP3+TNFR2+regulatory T cells. Curr Dir Autoimmun 2010, 11:119-134.
7. Varani K., Massara A., Vincenzi F., et al. Normalization of A2A and A3 adenosine receptor up-regulation in rheumatoid arthritis patients by treatment with anti-tumor necrosis factor alpha but not methotrexate. Arthritis Rheum 2009, 60:2880-2891.
8. Johansen C., Vinter H., Soegaard-Madsen L., et al. Preferential inhibition of the mRNA expression of p38 mitogen-activated protein kinase regulated cytokines in psoriatic skin by anti-TNFα therapy. Br J Dermatol 2010, 163:1194-1204.
9. Langrish C.L., Chen Y., Blumenschein W.M., et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005, 201:233-240.
10. Ramos-Casals M., Perez-Alvarez R., Perez-de-Lis M., et al. Pulmonary disorders induced by monoclonal antibodies in patients with rheumatologic autoimmune diseases. Am J Med 2011, 124:386-394.